|
Volumn 32, Issue SUPPL. 3, 2000, Pages
|
Helicobacter pylori-related extradigestive diseases and effects of eradication therapy
a a a a a a a a a |
Author keywords
Extradigestive diseases
|
Indexed keywords
ANTIBIOTIC AGENT;
BACTERIAL ANTIGEN;
C REACTIVE PROTEIN;
CLARITHROMYCIN;
CYTOKINE;
GAMMA INTERFERON;
HEAT SHOCK PROTEIN 60;
HEAT SHOCK PROTEIN 65;
IRON;
MACROLIDE;
METRONIDAZOLE;
REACTIVE OXYGEN METABOLITE;
TETRACYCLINE;
TUMOR NECROSIS FACTOR;
ANTIGEN ANTIBODY COMPLEX;
ARTICLE;
ATHEROGENESIS;
ATHEROSCLEROSIS;
AUTOIMMUNE DISEASE;
CHRONIC URTICARIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DISEASE ASSOCIATION;
ERADICATION THERAPY;
GRAM NEGATIVE INFECTION;
HASHIMOTO DISEASE;
HEART MUSCLE ISCHEMIA;
HELICOBACTER PYLORI;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
IMMUNE RESPONSE;
IRON DEFICIENCY ANEMIA;
IRON TRANSPORT;
ISCHEMIC HEART DISEASE;
RAYNAUD PHENOMENON;
RHEUMATOID ARTHRITIS;
ROSACEA;
STROKE;
ARTERIOSCLEROSIS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
RAYNAUD DISEASE;
ROSACEA;
|
EID: 0034493829
PISSN: 11258055
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (17)
|
References (23)
|